Biomarkers · Anthropometric

Hip Circumference

Higher values go with lower risk of death. Not measured in our NHANES panel. The curve is drawn from the published study (source below).

Hip Circumference and risk of death

Published curve higher than the NHANES fitNHANES fit higher

Risk of death relative to the curve's reference value, drawn from the published study (source below).

Published risk of death0.90×per 10 cm increase in hip circumference (95% CI 0.81–0.99) · Dose-response meta-analysis of prospective cohorts in the general population (72 cohorts overall; 9 for hip circumference)

Hip Circumference by age and sex

Each bar runs from the 5th to the 95th percentile, the darker part from the 25th to the 75th, and the tick is the median. Not a reference range or a target.

The percentiles as a table

Each row is one sex and age band: the values below which 5%, 25%, 50%, 75% and 95% of people fall (cm), from the survey named in the row. Not a reference range or a target.
Sex	Age	5th	25th	Median	75th	95th	n	Cycle / source
All	20-39	87.6	96.5	104	114	133	1,468	NHANES 2017-2018
All	40-59	88.4	98.6	106	116	136	1,584	NHANES 2017-2018
All	60+	89.9	98.7	106	114	134	1,851	NHANES 2017-2018
All	all	88.6	97.8	105	115	134	4,903	NHANES 2017-2018
Men	20-39	86.9	96.4	103	111	128	710	NHANES 2017-2018
Men	40-59	90.7	98.7	105	113	129	747	NHANES 2017-2018
Men	60+	89.3	98.5	104	112	129	953	NHANES 2017-2018
Men	all	88.9	97.5	104	112	128	2,410	NHANES 2017-2018
Women	20-39	88.0	96.7	106	117	138	758	NHANES 2017-2018
Women	40-59	88.1	98.6	107	120	142	837	NHANES 2017-2018
Women	60+	90.2	98.8	107	117	136	898	NHANES 2017-2018
Women	all	88.3	98.0	107	118	138	2,493	NHANES 2017-2018

What studies found when this marker was changed

They describe what happened in those study groups, not a recommendation. See all catalogued interventions.

Measured changes in Hip Circumference, study by study

4 effects with a numeric size, each from one study arm: the dot is the reported change, the line its 95% interval where one was given. Green points move the marker the way lower risk of death lies; amber the other way. Study results in the groups studied, not predictions for a person.

Each row is one study: what was changed, the effect it reported on this marker, and the source.
Type	Intervention	Reported effect	Evidence	Source
clinical	Electro-acupuncture at eight abdominal/leg acupoints twice weekly for 8 weeks in adults with central obesity	Hip circumference MD -2.0 cm (95% CI -3.7 to -1.7) over treatment and follow-up	RCT	Lam TF, et al. BMC Complement Med Ther. 2024. Electro-acupuncture for central…
diet	DASH eating pattern (52% carbohydrate, 18% protein, 30% fat, <2400 mg sodium) for 8 weeks in overweight/obese women with PCOS	Hip circumference -5.9 cm vs -1 cm with control diet over 8 weeks (p<0.0001)	RCT	Asemi Z, et al. Horm Metab Res. 2015. DASH diet, insulin resistance, and serum…
exercise	Combined aerobic plus resistance training programmes in breast cancer patients and survivors with overweight/obesity (17 RCTs)	Hip circumference MD -3.14 cm (p=0.02) with combined training	meta-analysis	Al-Mhanna SB, et al. J Sports Sci Med. 2024. Combined Aerobic and Resistance…
supplement	Daily oral pasteurized Akkermansia muciniphila (10^10 bacteria) for 3 months in overweight/obese insulin-resistant adults	Hip circumference -2.63 ± 1.14 cm vs baseline with pasteurized A. muciniphila (P = 0.091, not significant)	RCT	Depommier C, et al. Nat Med. 2019. Supplementation with Akkermansia muciniphila…

What else moves this marker

They describe those study groups, not an individual, and an association is not a cause.

Environmental and occupational exposures

Each row is one study: what it compared and the change it reported in this marker.
What	Effect on the marker	Comparison · population	Source
↑ Tobacco smoking initiation (genetically proxied) · genetic liability to smoking initiation, 378 variants	+0.4 cm (95% CI 0.23 to 0.57)	genetically predicted smoking initiation vs never initiating · 337,138 white British UK Biobank participants aged 40-69 years	mendelian randomization · PMID 37634025

Sources

Risk curve: Jayedi 2020 (PMID 32967840): all-cause HR 0.9 (0.81-0.99) per 10 cm increase in hip circumference. Scaled to US values (NHANES).
Jayedi et al. Central fatness and risk of all cause mortality: systematic review and dose-response meta-analysis of 72 prospective cohort studies. BMJ (Clinical research ed.). 2020;370:m3324.

Map Hip Circumference against another biomarker.

Map Hip Circumference against another marker